{"disease":{"id":"hearing-loss-sudden","name":"hearing loss sudden"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05474963","title":"Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Wonju Severance Christian Hospital","has_results":false},{"nct_id":"NCT06365775","title":"Multi-omics Characteristics and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Dan Bing","has_results":false},{"nct_id":"NCT05455398","title":"Establishment of a Trans-round Window Inner Ear Continuous Drug Delivery System for the Treatment of Severe-to-profound Sudden Sensorineural Hearing Loss","phase":"NA","overall_status":"UNKNOWN","enrollment_count":218,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05086276","title":"FX-322 in Adults With Acquired Sensorineural Hearing Loss","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"Frequency Therapeutics","has_results":true},{"nct_id":"NCT07472023","title":"Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss","phase":"EARLY_PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"Truway Health, Inc.","has_results":false},{"nct_id":"NCT04120116","title":"FX-322 in Adults With Stable Sensorineural Hearing Loss","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Frequency Therapeutics","has_results":true},{"nct_id":"NCT05052944","title":"Single-sided Deafness and Cochlear Implantation","phase":"","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04629664","title":"FX-322 in Adults With Severe Sensorineural Hearing Loss","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Frequency Therapeutics","has_results":false},{"nct_id":"NCT04601909","title":"FX-322 in Adults With Age-Related Sensorineural Hearing Loss","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Frequency Therapeutics","has_results":false},{"nct_id":"NCT06437054","title":"Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04766853","title":"Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Seoul National University Hospital","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}